Dr. Rajit Rattan

Dr. Rajit Rattan is a Consultant in Medical Oncology at Medanta – The Medicity, Gurugram, one of India's leading tertiary cancer care centres. With over 12 years of clinical experience and a robust international credential base, Dr. Rattan combines evidence-based medicine with a patient-centric approach to deliver comprehensive cancer management. He holds the MRCP (UK) Clinical Certificate in Medical Oncology and ESMO certification from the European Society of Medical Oncology, ensuring his practice aligns with the highest global standards.

Dr. Rattan's clinical expertise spans the full spectrum of solid organ malignancies—lung, breast, gynaecological, gastrointestinal, and urological cancers. His treatment portfolio includes chemotherapy, immunotherapy, targeted therapy, biomarker-based precision medicine, and palliative care. He has been recognised for his academic contributions, including a Bronze Medal in MD Radiotherapy and Oncology from PGIMER Chandigarh (2014), and has presented original research at national and international conferences. His published work appears in peer-reviewed journals such as the Annals of Translational Medicine and the British Journal of Radiology.

Dr. Rattan regularly treats international patients from the Gulf region, Africa, and South Asia who seek advanced oncology care without leaving their home countries for routine consultations. He offers telemedicine consultations, detailed case reviews, and coordinated care pathways that make it easy for overseas patients to access world-class treatment planning. His fluency in English and Hindi, combined with his experience managing culturally diverse patient populations, ensures clear communication and comfort throughout the treatment journey.

Medanta – The Medicity is a JCI-accredited, 1,200-bed multispecialty institution renowned for its comprehensive oncology services, state-of-the-art imaging, and dedicated chemotherapy infusion centres. The hospital's international patient services team ensures seamless coordination of travel, accommodation, and follow-up care. International patients appreciate the hospital's transparent pricing, English-speaking staff, and access to the latest immunotherapy and targeted therapy protocols. Dr. Rattan's practice at Medanta offers the clinical rigour of a major cancer centre combined with the personalised attention that international patients value when choosing their oncology care abroad.